Avid Bioservices, Inc. Announces Addition of Novel Bacteriophage Production System at Upcoming Biotechnology Industry Organization (BIO) Conference as Part of a Collaboration With Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.)
6/12/2012 8:36:34 AM
More...
|
Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.) to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations
12/21/2011 6:03:25 AM
More...
|
Company Profile for Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.)
8/27/2010 9:56:29 AM
More...
|
Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.) Appoints David Jackson as Vice President, Operations Planning
7/19/2010 10:27:06 AM
More...
|
Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.) Launched; Receives Funding for Purchase of Assets
5/24/2010 7:53:22 AM
More...
|
Phage Biotechnology Corp. Engages The Bruckner Group to Find a Joint Commercialization Partner for Phage's Portfolio of Recombinant Protein Biopharmaceuticals, Technologies, and Development Platforms
11/15/2007 9:10:00 AM
More...
|
Phage Biotechnology Corp. Engages The Bruckner Group To Find A Joint Commercialization Partner For Phage's Portfolio Of Recombinant Protein Biopharmaceuticals, Technologies, and Development Platforms
11/6/2007 9:36:53 AM
More...
|